ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
20.96
+0.30 (1.45%)
Nov 19, 2024, 4:00 PM EST
ZIVO Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.16 | 0.27 | 1.8 | 8.9 | 0.14 | 0.35 | Upgrade
|
| Cash & Short-Term Investments | 0.16 | 0.27 | 1.8 | 8.9 | 0.14 | 0.35 | Upgrade
|
| Cash Growth | -89.26% | -84.75% | -79.79% | 6357.09% | -60.17% | -11.00% | Upgrade
|
| Receivables | 0.03 | 0 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 0.25 | 0.15 | 0.1 | 0.06 | 0.03 | 0.02 | Upgrade
|
| Total Current Assets | 0.44 | 0.43 | 1.9 | 8.96 | 0.17 | 0.37 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.1 | 0.19 | 0.03 | 0.05 | - | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.03 | 0.03 | 0 | 0 | - | Upgrade
|
| Total Assets | 0.5 | 0.56 | 2.12 | 8.99 | 0.22 | 0.37 | Upgrade
|
| Accounts Payable | 0.92 | 1.17 | 0.49 | 0.65 | 1.56 | 1.37 | Upgrade
|
| Accrued Expenses | 1.23 | 1.25 | 0.5 | 0.56 | 2.68 | 2.06 | Upgrade
|
| Short-Term Debt | 0.12 | - | - | - | 0.01 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.24 | 0.24 | 0.24 | 0.24 | 5.18 | 5.28 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.11 | 0.1 | 0.02 | 0.03 | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.7 | 1.48 | 1.94 | - | Upgrade
|
| Other Current Liabilities | 0.05 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 2.58 | 2.76 | 2.03 | 2.95 | 11.39 | 8.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.12 | - | Upgrade
|
| Long-Term Leases | - | - | 0.11 | - | 0.02 | - | Upgrade
|
| Total Liabilities | 2.58 | 2.76 | 2.13 | 2.95 | 11.53 | 8.71 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | 0.4 | Upgrade
|
| Additional Paid-In Capital | 133.28 | 121.37 | 115.79 | 113.09 | 87.75 | 81.22 | Upgrade
|
| Retained Earnings | -135.37 | -123.58 | -115.8 | -107.06 | -99.06 | -89.96 | Upgrade
|
| Shareholders' Equity | -2.08 | -2.21 | -0.01 | 6.04 | -11.31 | -8.34 | Upgrade
|
| Total Liabilities & Equity | 0.5 | 0.56 | 2.12 | 8.99 | 0.22 | 0.37 | Upgrade
|
| Total Debt | 0.38 | 0.35 | 0.45 | 0.26 | 5.36 | 5.28 | Upgrade
|
| Net Cash (Debt) | -0.22 | -0.07 | 1.35 | 8.65 | -5.22 | -4.93 | Upgrade
|
| Net Cash Growth | - | - | -84.34% | - | - | - | Upgrade
|
| Net Cash Per Share | -0.08 | -0.04 | 0.86 | 6.80 | -6.17 | -8.57 | Upgrade
|
| Filing Date Shares Outstanding | 3.49 | 2.78 | 1.57 | 1.57 | 0.87 | 0.84 | Upgrade
|
| Total Common Shares Outstanding | 3.49 | 2.38 | 1.57 | 1.57 | 0.83 | 0.83 | Upgrade
|
| Working Capital | -2.14 | -2.34 | -0.13 | 6.01 | -11.23 | -8.34 | Upgrade
|
| Book Value Per Share | -0.60 | -0.93 | -0.01 | 3.85 | -13.68 | -10.09 | Upgrade
|
| Tangible Book Value | -2.08 | -2.21 | -0.01 | 6.04 | -11.31 | -8.34 | Upgrade
|
| Tangible Book Value Per Share | -0.60 | -0.93 | -0.01 | 3.85 | -13.68 | -10.09 | Upgrade
|
| Machinery | - | - | - | - | 0.1 | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.